U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07662174) titled 'Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage' on May 29.
Brief Summary: Hydrocephalus is a serious condition in which fluid builds up inside the brain, often requiring lifelong surgical placement of a shunt to drain excess cerebrospinal fluid (CSF). One of the most common causes of hydrocephalus is bleeding into the brain's fluid spaces after aneurysm rupture, prematurity, or infection. Currently, no medication exists to prevent hydrocephalus from developing after these injuries. The investigators' recent research suggests that hydrocephalus may result not only from blocked fluid pathways but also from...